🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Myocardial Infarction in the Elderly

Recruitingn/aAges 75 Years - anyAllRyazan State Medical University
NCT06860646 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An observational registry study of patients aged 75 years and older with an established diagnosis of myocardial infarction, initiated in 2020, with an assessment of clinical, instrumental, demographic and prognostic data. Statistical analysis was performed using the StatTech v. 4.5.0 program (developer - StatTech LLC, Russia). Differences were considered statistically significant at p \<0.05.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization. Exclusion Criteria: \-
💊

What it tests

  • Not listed
📍

Where

1 site
State Budgetary Institution of the Ryazan Region "Regional Clinical Cardiology Dispensary"
Ryazan, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy